Insider transactions

EDGAR

KYMERA THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
2 transactions, 2,005,813 shares
Sum of shares × price per share: 172,499,918
Open-market sales (code S)
274 transactions, 4,560,526 shares
Sum of shares × price per share: 473,286,847.7549

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 386

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)30,0002.08
62,400

Derived: shares × price per share. Exact value 62400.00.

696,568Direct (D) Yes
F1
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,525111.44
392,826

Derived: shares × price per share. Exact value 392826.00.

693,043Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.93 to $111.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,506112.42
618,984.52

Derived: shares × price per share. Exact value 618984.52.

687,537Direct (D) Yes
F1, F3
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.97 to $112.92 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,876113.24
552,158.24

Derived: shares × price per share. Exact value 552158.24.

682,661Direct (D) Yes
F1, F4
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.95 to $113.88 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,601114.43
869,782.43

Derived: shares × price per share. Exact value 869782.43.

675,060Direct (D) Yes
F1, F5
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.94 to $114.91 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,230115.40
949,742

Derived: shares × price per share. Exact value 949742.00.

666,830Direct (D) Yes
F1, F6
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.94 to $115.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)262116.12
30,423.44

Derived: shares × price per share. Exact value 30423.44.

666,568Direct (D) Yes
F1, F7
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $116.16 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-01Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (30,000) — exercise price 2.08
Disposed (D)30,0000—60,000Direct (D) Yes
F1, F8
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F8 The shares underlying this stock option are fully vested and exercisable.
Open filing 0001193125-26-410839 Read from the filing’s XML Dispute this row
2026-09-04 Filed 2026-09-04Adams Brian Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,209115.55
139,699.95

Derived: shares × price per share. Exact value 139699.95.

55,416Direct (D) No
F1, F2
  • F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.09 to $116.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row
2026-09-04 Filed 2026-09-04Adams Brian Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,025116.81
353,350.25

Derived: shares × price per share. Exact value 353350.25.

52,391Direct (D) No
F1, F3
  • F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.09 to $117.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row
2026-09-04 Filed 2026-09-04Adams Brian Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,137117.57
251,247.09

Derived: shares × price per share. Exact value 251247.09.

50,254Direct (D) No
F1, F4
  • F1 Represents shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not in the discretion of the Reporting Person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.38 to $117.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-383874 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-27Rooney Terence Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)38,0000—38,000Direct (D) No
F1
  • F1 Represents restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. The RSUs shall vest in four equal annualinstallments following July 27, 2026, subject to the reporting person's continued employment through each vesting date.
Open filing 0001193125-26-318408 Read from the filing’s XML Dispute this row
2026-07-27 Filed 2026-07-27Rooney Terence Officer: Chief Medical Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (76,000) — exercise price 110.05
Acquired (A)76,0000—76,000Direct (D) No
F2
  • F2 Twenty-five percent (25%) of the shares underlying this stock option shall vest on July 27, 2027, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the reporting person's continued employment through each vesting date.
Open filing 0001193125-26-318408 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-07Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)50,0002.08
104,000

Derived: shares × price per share. Exact value 104000.00.

716,568Direct (D) Yes
F1
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-07Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)50,000119
5,950,000

Derived: shares × price per share. Exact value 5950000.

666,568Direct (D) Yes
F1
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-07Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (45,559) — exercise price 2.08
Disposed (D)45,5590—90,000Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F2 The shares underlying this stock option are fully vested and exercisable.
Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row
2026-07-07 Filed 2026-07-07Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (4,441) — exercise price 2.08
Disposed (D)4,4410—14,284Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F2 The shares underlying this stock option are fully vested and exercisable.
Open filing 0001193125-26-297817 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)80,0002.08
166,400

Derived: shares × price per share. Exact value 166400.00.

746,568Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F2 This number includes 373 shares acquired under the Registrant's employee stock purchase plan.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,883112.8046
212,411.0618

Derived: shares × price per share. Exact value 212411.0618.

744,685Direct (D) Yes
F1, F3
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.28 to $113.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,626113.9758
755,203.6508

Derived: shares × price per share. Exact value 755203.6508.

738,059Direct (D) Yes
F1, F4
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.36 to $114.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)24,105114.9555
2,771,002.3275

Derived: shares × price per share. Exact value 2771002.3275.

713,954Direct (D) Yes
F1, F5
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.29 to $115.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)44,050115.6883
5,096,069.615

Derived: shares × price per share. Exact value 5096069.6150.

669,904Direct (D) Yes
F1, F6
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.31 to $116.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,336116.559
388,840.824

Derived: shares × price per share. Exact value 388840.824.

666,568Direct (D) Yes
F1, F7
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.29 to $116.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Mainolfi Nello Director · Officer: Chief Executive Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (80,000) — exercise price 2.08
Disposed (D)80,0000—135,559Direct (D) Yes
F1, F8
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.
  • F8 The shares underlying this stock option are fully vested and exercisable.
Open filing 0001193125-26-295088 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-02Goodman Noah Officer: Chief Business Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,389114.29
387,328.81

Derived: shares × price per share. Exact value 387328.81.

47,179.438Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated December 10, 2025 adopted by the reporting person.
  • F2 This number includes 373 shares acquired under the Registrant's employee stock purchase plan.
Open filing 0001193125-26-295089 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)61,3785.33
327,144.74

Derived: shares × price per share. Exact value 327144.74.

321,992Direct (D) Yes
F1, F2
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F2 This number includes 373 shares acquired under the Registrant's employee stock purchase plan.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,500110.5397
165,809.55

Derived: shares × price per share. Exact value 165809.5500.

320,492Direct (D) Yes
F1, F3
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.37 to $110.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,700111.5671
189,664.07

Derived: shares × price per share. Exact value 189664.0700.

318,792Direct (D) Yes
F1, F4
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.41 to $112.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,100112.7881
124,066.91

Derived: shares × price per share. Exact value 124066.9100.

317,692Direct (D) Yes
F1, F5
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.49 to $113.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,110114.1875
469,310.625

Derived: shares × price per share. Exact value 469310.6250.

313,582Direct (D) Yes
F1, F6
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.49 to $114.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)51,375114.7696
5,896,288.2

Derived: shares × price per share. Exact value 5896288.2000.

262,207Direct (D) Yes
F1, F7
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.49 to $115.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,971115.8171
923,178.1041

Derived: shares × price per share. Exact value 923178.1041.

254,236Direct (D) Yes
F1, F8
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.49 to $116.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,153116.9937
719,862.2361

Derived: shares × price per share. Exact value 719862.2361.

248,083Direct (D) Yes
F1, F9
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.49 to $117.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)3,200117.7029
376,649.28

Derived: shares × price per share. Exact value 376649.2800.

244,883Direct (D) Yes
F1, F10
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.55 to $118.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Jacobs Bruce N. Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (61,378) — exercise price 5.33
Disposed (D)61,3780—0Direct (D) Yes
F1, F11
  • F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 23, 2026 adopted by the reporting person.
  • F11 The shares underlying this stock option are fully vested and exercisable.
Open filing 0001193125-26-295090 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,549105.78
586,973.22

Derived: shares × price per share. Exact value 586973.22.

2,446,375Indirect (I) See footnoteYes
F1, F2, F3, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.015 to $106.0145 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (3) and (5) through (10).
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)14,798106.63
1,577,910.74

Derived: shares × price per share. Exact value 1577910.74.

2,431,577Indirect (I) See footnoteYes
F1, F2, F5, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.0271 to $106.96 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)19,419107.76
2,092,591.44

Derived: shares × price per share. Exact value 2092591.44.

2,412,158Indirect (I) See footnoteYes
F1, F2, F6, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.03 to $108.0293 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,848108.28
1,174,621.44

Derived: shares × price per share. Exact value 1174621.44.

2,401,310Indirect (I) See footnoteYes
F1, F2, F7, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.0326 to $109.019 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,968109.75
874,488

Derived: shares × price per share. Exact value 874488.00.

2,393,342Indirect (I) See footnoteYes
F1, F2, F8, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.034 to $109.96 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)7,723110.67
854,704.41

Derived: shares × price per share. Exact value 854704.41.

2,385,619Indirect (I) See footnoteYes
F1, F2, F9, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $111.08 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)934111.20
103,860.8

Derived: shares × price per share. Exact value 103860.80.

2,384,685Indirect (I) See footnoteYes
F1, F2, F10, F4
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.09 to $111.63 inclusive.
  • F4 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)770105.78
81,450.6

Derived: shares × price per share. Exact value 81450.60.

471,497Indirect (I) See footnoteYes
F1, F2, F3, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $105.015 to $106.0145 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (3) and (5) through (10).
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,133106.63
227,441.79

Derived: shares × price per share. Exact value 227441.79.

469,364Indirect (I) See footnoteYes
F1, F2, F5, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.0271 to $106.96 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,698107.76
290,736.48

Derived: shares × price per share. Exact value 290736.48.

466,666Indirect (I) See footnoteYes
F1, F2, F6, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.03 to $108.0293 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,498108.28
162,203.44

Derived: shares × price per share. Exact value 162203.44.

465,168Indirect (I) See footnoteYes
F1, F2, F7, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.0326 to $109.019 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,104109.75
121,164

Derived: shares × price per share. Exact value 121164.00.

464,064Indirect (I) See footnoteYes
F1, F2, F8, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.034 to $109.96 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,078110.67
119,302.26

Derived: shares × price per share. Exact value 119302.26.

462,986Indirect (I) See footnoteYes
F1, F2, F9, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.09 to $111.08 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)130111.20
14,456

Derived: shares × price per share. Exact value 14456.00.

462,856Indirect (I) See footnoteYes
F1, F2, F10, F11
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The number of shares disposed and the number of shares owned following reported transaction were inadvertently misreported on the original Form 4. This represents to correct number.
  • F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.09 to $111.63 inclusive.
  • F11 The shares are owned directly by Atlas Venture Opportunity Fund I, L.P. (AVOF). Atlas Venture Associates Opportunity I, L.P. (AVAO LP) is the general partner of AVOF. Atlas Venture Associates Opportunity I, LLC (AVAO LLC) is the general partner of AVAO LP. The Reporting Person is a member of AVAO LLC and disclaims Section 16 beneficial ownership of such securities held by AVOF, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000022 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Booth Bruce Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)10,658108.28
1,154,048.24

Derived: shares × price per share. Exact value 1154048.24.

2,402,089Indirect (I) See footnoteYes
F1, F2, F3
  • F1 This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Atlas Venture Fund X, L.P. and Atlas Venture Opportunity Fund I, L.P. on December 11, 2025.
  • F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.0326 to $109.019 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnotes (2) and (4) through (6).
  • F3 These shares are held directly by Atlas Venture Fund X, L.P. (Atlas Venture Fund X). The general partner of Atlas Venture Fund X is Atlas Venture Associates X, L.P. (AVA X LP). Atlas Venture Associates X, LLC (AVA X LLC) is the general partner of AVA X LP. The Reporting Person is a member of AVA X LLC and disclaims Section 16 beneficial ownership of the securities held by Atlas Venture Fund X, except to the extent of his pecuniary interest therein, if any.
Open filing 0001451612-26-000020 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.

Showing 1–50 of 319

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
FMR LLC Partly reported under another manager12,568,921 SH1,405,079,714 dollarsHigher by 219,665 Prior quarter: 12,349,256Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager8,725,908 SH975,470 dollarsHigher by 1,612,928 Prior quarter: 7,112,980Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
BAKER BROS. ADVISORS LP 8,657,242 SH967,793,083 dollarsUnchanged Prior quarter: 8,657,242Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row
Avoro Capital Advisors LLC 7,474,747 SH835,601,967 dollarsUnchanged Prior quarter: 7,474,747Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager5,825,416 SH651,223,250 dollarsHigher by 287,206 Prior quarter: 5,538,210Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
T. Rowe Price Investment Management, Inc. 5,736,316 SH641,263 dollarsLower by 520,945 Prior quarter: 6,257,261Open filing 0001897612-26-000766 Filed 2026-11-16 Dispute this row
BVF INC/IL Partly reported under another manager3,872,052 SH432,856,693 dollarsUnchanged Prior quarter: 3,872,052Open filing 0000921895-26-003162 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager3,706,994 SH414,404,859 dollarsHigher by 31,966 Prior quarter: 3,675,028Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 3,044,214 SH340,312,683 dollarsHigher by 111,836 Prior quarter: 2,932,378Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 2,978,521 SH332,968,863 dollarsLower by 13,672 Prior quarter: 2,992,193Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
Atlas Venture Life Science Advisors, LLC 2,847,541 SH318,326,608 dollarsUnchanged Prior quarter: 2,847,541Open filing 0001104659-26-125242 Filed 2026-11-10 Dispute this row
Siren, L.L.C. Partly reported under another manager2,784,898 SH311,323,747 dollarsLower by 150,932 Prior quarter: 2,935,830Open filing 0002005245-26-000013 Filed 2026-11-12 Dispute this row
STATE STREET CORP Partly reported under another manager2,582,973 SH288,750,552 dollarsLower by 154,253 Prior quarter: 2,737,226Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,913,528 SH213,956,388 dollarsHigher by 97,197 Prior quarter: 1,816,331Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,208,462 SH135,093,968 dollarsHigher by 21,129 Prior quarter: 1,187,333Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Capital Research Global Investors Partly reported under another manager1,130,378 SH126,364,957 dollarsLower by 258,503 Prior quarter: 1,388,881Open filing 0001422848-26-000129 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager1,034,482 SH115,644,743 dollarsHigher by 26,705 Prior quarter: 1,007,777Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 886,951 SH99,152,252 dollarsHigher by 357,222 Prior quarter: 529,729Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager819,071 SH91,563,947 dollarsLower by 162,450 Prior quarter: 981,521Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Driehaus Capital Management LLC 808,098 SH90,337,275 dollarsLower by 111,135 Prior quarter: 919,233Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row
Merck Co., Inc. 772,165 SH86,320,325 dollarsUnchanged Prior quarter: 772,165Open filing 0000310158-26-000249 Filed 2026-11-13 Dispute this row
FEDERATED HERMES, INC. Partly reported under another manager747,432 SH83,555,423 dollarsLower by 1,966 Prior quarter: 749,398Open filing 0001623632-26-001675 Filed 2026-11-12 Dispute this row
Holocene Advisors, LP 721,687 SH80,677,390 dollarsHigher by 85,108 Prior quarter: 636,579Open filing 0001172661-26-005338 Filed 2026-11-16 Dispute this row
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Partly reported under another manager702,329 SH78,513,362 dollarsLower by 34,537 Prior quarter: 736,866Open filing 0000861177-26-000005 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager693,290 SH77,496,888 dollarsLower by 51,862 Prior quarter: 745,152Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Hood River Capital Management LLC 637,295 SH71,243,208 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-014212 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager604,045 SH67,526,191 dollarsHigher by 22,138 Prior quarter: 581,907Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
FRONTIER CAPITAL MANAGEMENT CO LLC 564,133 SH63,064,428 dollarsLower by 176,733 Prior quarter: 740,866Open filing 0001172661-26-005367 Filed 2026-11-16 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager552,284 SH75,248,696 dollarsHigher by 37,234 Prior quarter: 515,050Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
Boxer Capital Management, LLC 524,551 SH58,639,556 dollarsHigher by 95,451 Prior quarter: 429,100Open filing 0001213900-26-120704 Filed 2026-11-16 Dispute this row
JENNISON ASSOCIATES LLC Partly reported under another manager509,160 SH56,918,997 dollarsHigher by 6,182 Prior quarter: 502,978Open filing 0000053417-26-000068 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 503,090 SH56,240,431 dollarsHigher by 53,359 Prior quarter: 449,731Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Woodline Partners LP 500,868 SH55,992,034 dollarsUnchanged Prior quarter: 500,868Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
EVENTIDE ASSET MANAGEMENT, LLC 490,611 SH54,843,362 dollarsLower by 13,599 Prior quarter: 504,210Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager474,764 SH53,073,867 dollarsHigher by 96,478 Prior quarter: 378,286Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Rock Springs Capital Management LP 409,631 SH45,792,649 dollarsLower by 43,525 Prior quarter: 453,156Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
Clearbridge Investments, LLC 396,827 SH44,361,290 dollarsHigher by 49,606 Prior quarter: 347,221Open filing 0001348883-26-000026 Filed 2026-11-12 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager382,804 SH42,793,659 dollarsHigher by 6,936 Prior quarter: 375,868Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
MORGAN STANLEY Partly reported under another manager359,192 SH40,154,171 dollarsHigher by 164,349 Prior quarter: 194,843Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Fisher Asset Management, LLC Partly reported under another manager323,219 SH36,132,651 dollarsHigher by 310,487 Prior quarter: 12,732Open filing 0000850529-26-000009 Filed 2026-11-06 Dispute this row
BRAIDWELL LP 300,569 SH33,600,609 dollarsLower by 77,594 Prior quarter: 378,163Open filing 0001420506-26-002894 Filed 2026-11-16 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 300,000 SH33,537,000 dollarsHigher by 100,000 Prior quarter: 200,000Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
Pictet Asset Management Holding SA 298,928 SH33,363,049 dollarsLower by 96,612 Prior quarter: 395,540Open filing 0001993888-26-000007 Filed 2026-11-03 Dispute this row
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager296,062 SH33,096,772 dollarsHigher by 26,148 Prior quarter: 269,914Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
Nextech Invest Ltd. 278,896 SH31,177,784 dollarsUnchanged Prior quarter: 278,896Open filing 0001595430-26-000015 Filed 2026-11-16 Dispute this row
LORD, ABBETT CO. LLC 246,777 SH27,587 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row
RTW INVESTMENTS, LP 240,000 SH26,829,600 dollarsUnchanged Prior quarter: 240,000Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row
Connor, Clark Lunn Investment Management Ltd. 233,521 SH26,105,313 dollarsHigher by 83,613 Prior quarter: 149,908Open filing 0001596800-26-000018 Filed 2026-11-10 Dispute this row
TD ASSET MANAGEMENT INC 227,184 SH25,106,104 dollarsLower by 45,716 Prior quarter: 272,900Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager224,961 SH25,168,637 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • NORGES BANK 757,246 SH
  • Sixth Street Partners Management Company, L.P. 529,729 SH
  • BOONE CAPITAL MANAGEMENT LLC 113,173 SH
  • CITADEL ADVISORS LLC 111,555 SH
  • Burkehill Global Management, LP 75,000 SH
  • NEW YORK STATE COMMON RETIREMENT FUND 28,780 SH
  • SCHRODER INVESTMENT MANAGEMENT GROUP 27,997 SH
  • SILVERARC CAPITAL MANAGEMENT, LLC 25,000 SH
  • Freestone Grove Partners LP 21,176 SH
  • Jupiter Topco LLC 21,058 SH
  • Man Group plc 19,085 SH
  • Jump Financial, LLC 13,803 SH
  • Susquehanna Portfolio Strategies, LLC 13,768 SH
  • Scientech Research LLC 12,943 SH
  • Virtu Financial LLC 12,556 SH
  • Jupiter Research Capital (Asia) Ltd 9,901 SH
  • GSA CAPITAL PARTNERS LLP 7,343 SH
  • Aster Capital Management (DIFC) Ltd 5,661 SH
  • Blackstone Inc. 5,087 SH
  • SG Americas Securities, LLC 4,674 SH
  • ALGERT GLOBAL LLC 3,430 SH
  • TWO SIGMA SECURITIES, LLC 2,716 SH
  • DLD Asset Management, LP 2,500 SH
  • Empowered Funds, LLC 2,338 SH
  • Mitsubishi UFJ Trust Banking Corp 1,376 SH
  • ACADIAN ASSET MANAGEMENT LLC 1,035 SH
  • MERCER GLOBAL ADVISORS INC /ADV 916 SH
  • SUMMIT SECURITIES GROUP LLC 750 SH
  • Pacer Advisors, Inc. 589 SH
  • Optiver Holding B.V. 297 SH
  • Truvestments Capital LLC 104 SH
  • AdvisorNet Financial, Inc 60 SH
  • BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 16 SH
  • Integrated Wealth Concepts LLC 15 SH
  • FIDUCIARY FINANCIAL ADVISORS 14 SH
  • Stone House Investment Management, LLC 5 SH
  • HFM Investment Advisors, LLC 2 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BlackRock, Inc. Common Stock6.65,450,28609/30/2026 Filed 2026-10-27SCHEDULE 13G/AAmendment 4Open filing 0002012383-26-003919 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK10.78,873,58808/31/2026 Filed 2026-09-08SCHEDULE 13G/AAmendment 8Open filing 0000080255-26-000601 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK8.67,112,34506/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 7Open filing 0000080255-26-000572 Dispute this row
Atlas Venture Fund X, L.P. COMMON STOCK, $0.0001 PAR VALUE2.92,384,685.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
ATLAS VENTURE ASSOCIATES X, L.P. COMMON STOCK, $0.0001 PAR VALUE2.92,384,685.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
Atlas Venture Associates X, LLC COMMON STOCK, $0.0001 PAR VALUE2.92,384,685.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
Atlas Venture Opportunity Fund I, L.P. COMMON STOCK, $0.0001 PAR VALUE0.6462,856.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
Atlas Venture Associates Opportunity I, L.P. COMMON STOCK, $0.0001 PAR VALUE0.6462,856.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
Atlas Venture Associates Opportunity I, LLC COMMON STOCK, $0.0001 PAR VALUE0.6462,856.0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0001628098-26-000009 Dispute this row
BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share3.32,712,852.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF I GP LLC Common Stock, $0.0001 par value per share3.32,712,852.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share2.62,124,859.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF II GP LLC Common Stock, $0.0001 par value per share2.62,124,859.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share0.4292,856.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF Partners OS Ltd. Common Stock, $0.0001 par value per share0.4292,856.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share5.84,837,711.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share6.35,237,151.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
BVF INC/IL Common Stock, $0.0001 par value per share6.35,237,151.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
LAMPERT MARK N Common Stock, $0.0001 par value per share6.35,237,151.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
Hrustanovic Gorjan Common Stock, $0.0001 par value per share0.1116,190.0006/26/2026 Filed 2026-06-26SCHEDULE 13D/AAmendment 6Open filing 0000921895-26-001687 Dispute this row
T. Rowe Price Investment Management, Inc. COMMON STOCK6.75,460,25703/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001897612-26-000493 Dispute this row
Wellington Management Group LLP Common Stock4.83,889,687.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 8Open filing 0000902219-26-000204 Dispute this row
Wellington Group Holdings LLP Common Stock4.83,889,687.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 8Open filing 0000902219-26-000204 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock4.83,889,687.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 8Open filing 0000902219-26-000204 Dispute this row
FMR LLC COMMON STOCK14.311,681,450.4503/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-001229 Dispute this row
Abigail P. Johnson COMMON STOCK14.311,681,450.4503/31/2026 Filed 2026-05-06SCHEDULE 13G/AAmendment 4Open filing 0000315066-26-001229 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 4Open filing 0000102909-26-001649 Dispute this row
Wellington Management Group LLP Common Stock5.54,412,933.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 7Open filing 0000902219-26-000017 Dispute this row
Wellington Group Holdings LLP Common Stock5.54,412,933.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 7Open filing 0000902219-26-000017 Dispute this row
Wellington Investment Advisors Holdings LLP Common Stock5.54,412,933.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 7Open filing 0000902219-26-000017 Dispute this row
Wellington Management Company LLP Common Stock5.34,412,933.0012/31/2025 Filed 2026-02-10SCHEDULE 13G/AAmendment 7Open filing 0000902219-26-000017 Dispute this row
FMR LLC COMMON STOCK11.28,928,574.1212/31/2025 Filed 2026-01-08SCHEDULE 13G/AAmendment 3Open filing 0000315066-26-000053 Dispute this row
Abigail P. Johnson COMMON STOCK11.28,928,574.1212/31/2025 Filed 2026-01-08SCHEDULE 13G/AAmendment 3Open filing 0000315066-26-000053 Dispute this row
BIOTECHNOLOGY VALUE FUND L P Common Stock, $0.0001 par value per share4.43,550,766.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF I GP LLC Common Stock, $0.0001 par value per share4.43,550,766.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BIOTECHNOLOGY VALUE FUND II LP Common Stock, $0.0001 par value per share3.42,752,456.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF II GP LLC Common Stock, $0.0001 par value per share3.42,752,456.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
Biotechnology Value Trading Fund OS LP Common Stock, $0.0001 par value per share0.5406,145.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF Partners OS Ltd. Common Stock, $0.0001 par value per share0.5406,145.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF GP HOLDINGS LLC Common Stock, $0.0001 par value per share7.86,303,222.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF PARTNERS L P/IL Common Stock, $0.0001 par value per share8.56,867,809.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
BVF INC/IL Common Stock, $0.0001 par value per share8.56,867,809.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
LAMPERT MARK N Common Stock, $0.0001 par value per share8.56,867,809.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
Hrustanovic Gorjan Common Stock, $0.0001 par value per share0.1100,190.0012/11/2025 Filed 2025-12-15SCHEDULE 13D/AAmendment 5Open filing 0000921895-25-003346 Dispute this row
Baker Bros. Advisors LP Common Stock, $0.0001 par value per share10.98,676,797.0012/09/2025 Filed 2025-12-11SCHEDULE 13D/AAmendment 3Open filing 0001104659-25-120356 Dispute this row
Baker Bros. Advisors (GP) LLC Common Stock, $0.0001 par value per share10.98,676,797.0012/09/2025 Filed 2025-12-11SCHEDULE 13D/AAmendment 3Open filing 0001104659-25-120356 Dispute this row
Julian C. Baker Common Stock, $0.0001 par value per share10.98,676,797.0012/09/2025 Filed 2025-12-11SCHEDULE 13D/AAmendment 3Open filing 0001104659-25-120356 Dispute this row
Felix J. Baker Common Stock, $0.0001 par value per share10.98,676,797.0012/09/2025 Filed 2025-12-11SCHEDULE 13D/AAmendment 3Open filing 0001104659-25-120356 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK7.15,097,70409/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 6Open filing 0000080255-25-000835 Dispute this row
FMR LLC COMMON STOCK8.25,879,611.1209/30/2025 Filed 2025-11-05SCHEDULE 13G/AAmendment 2Open filing 0000315066-25-002767 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,312,501 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201517,836
2016207,737
2017207,865
2018202,770
2019215,153
2020144,184
2021224,474
2022158,941
2023199,811
2024209,823
2025235,520
2026260,174

Filings made before the SEC required XML are listed, not extracted.

Back to KYMERA THERAPEUTICS, INC.